Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 12;12(1):1654.
doi: 10.1038/s41467-021-21921-x.

ADAR1 RNA editing enzyme regulates R-loop formation and genome stability at telomeres in cancer cells

Affiliations

ADAR1 RNA editing enzyme regulates R-loop formation and genome stability at telomeres in cancer cells

Yusuke Shiromoto et al. Nat Commun. .

Abstract

ADAR1 is involved in adenosine-to-inosine RNA editing. The cytoplasmic ADAR1p150 edits 3'UTR double-stranded RNAs and thereby suppresses induction of interferons. Loss of this ADAR1p150 function underlies the embryonic lethality of Adar1 null mice, pathogenesis of the severe autoimmune disease Aicardi-Goutières syndrome, and the resistance developed in cancers to immune checkpoint blockade. In contrast, the biological functions of the nuclear-localized ADAR1p110 remain largely unknown. Here, we report that ADAR1p110 regulates R-loop formation and genome stability at telomeres in cancer cells carrying non-canonical variants of telomeric repeats. ADAR1p110 edits the A-C mismatches within RNA:DNA hybrids formed between canonical and non-canonical variant repeats. Editing of A-C mismatches to I:C matched pairs facilitates resolution of telomeric R-loops by RNase H2. This ADAR1p110-dependent control of telomeric R-loops is required for continued proliferation of telomerase-reactivated cancer cells, revealing the pro-oncogenic nature of ADAR1p110 and identifying ADAR1 as a promising therapeutic target of telomerase positive cancers.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. ADAR1 depletion resulted in abnormalities of the nucleus and upregulation of DNA damage pathway and cell cycle marker genes.
a HeLa cells were first transfected with siControl or siADAR1 (siADAR1-1) for 72 h and then treated with CellLight Tubulin-GFP. Nuclei were visualized by staining of DNA with SiR-DNA reagent. Representative images taken from real-time videos (Supplementary Movies S1 and 2) are presented. Scale bar, 50 μm. b The frequency of abnormalities of the nucleus (nucleoplasmic bridge, micronuclei, and multinuclei) was estimated by examining at least 200 individual HeLa cells treated with siControl or siADAR1-1 RNAs. Values are mean ± standard error (n = 3, biologically independent samples) with significant differences by two-tailed Student’s t test indicated, **P < 0.01. Scale bar, 5 μm. c Telomere DNA damages in ADAR1-depleted cells. Telomere FISH and immunostaining for γH2AX revealed significantly increased telomere dysfunction-induced foci (TIF, indicated by yellow arrowheads), suggesting the causative relevance of the telomeric repeat DNA damage to chromosome abnormality detected in ADAR1-depleted HeLa cells. At least 200 individual HeLa cells treated with siControl or siADAR1-1 RNAs were examined. HeLa cells with one or more TIFs were counted as TIF-positive cells. Values are mean ± SD (n = 3, biologically independent samples) with significant differences by two-tailed Student’s t test indicated, **P < 0.01. Scale bar, 10 μm. b, c All individual experimental data values and exact P values are presented in Source Data file. d Western blotting analysis was done using total cell extracts from HeLa cells treated with siControl or two separate siADAR1 (siADAR1-1 and -2) RNAs for 72 h. Protein molecular weight markers are presented in Source Data file. e The R-loop structure consisting of an RNA:DNA hybrid formed between the RNA strand newly transcribed by RNA polymerase II and the template DNA strand with the single-stranded antisense DNA bound with ssDNA-binding protein RPA as well as major regulators are schematically shown.
Fig. 2
Fig. 2. A-to-I editing activity of ADAR1p110, not ADAR1p150 or ADAR2, is required for suppression of R-loops.
ae Dot blot analysis for RNA:DNA hybrids was conducted using control oligos (a) or genomic DNA (b–e). a The S9.6 antibody recognized specifically RNA:DNA but not DNA:DNA or RNA:RNA oligo duplex controls. b, c Increased RNA:DNA hybrids were detected only in ADAR1-depleted but not in ADAR2-depleted HeLa cells. b The S9.6 antibody signals were abolished by E. coli-RNase H treatment, confirming specific detection of RNA:DNA hybrids. d Comparison of RNA:DNA hybrid levels between depletion of ADAR1 versus depletion of known R-loop regulators. e Increased RNA:DNA hybrid formation resulting from depletion of endogenous ADAR1 was rescued by infection of ADAR1p110-WT (wild type) but not by infection of ADAR1p110-E912A deamination defective mutant or ADAR1p150-WT. ce Data are mean ± SD (n = 3, biological replicates); significant differences were identified by two-tailed Student’s t tests: *P < 0.05, **P < 0.01, ***P < 0.001, n.s., not significant. All individual experimental data values and exact P values are presented in Source Data file.
Fig. 3
Fig. 3. Accumulation of R-loops at telomeres in ADAR1-depleted cells.
a ADAR1 depletion had no effects on already known sites prone to the formation of R-loops. Six sites were examined by qPCR analysis of DRIP products. PCR primers used are listed in Supplementary Data 1. Data are mean ± SD (n = 3, biological replicates); significant differences were identified by two-tailed Student’s t tests: n.s., not significant. b DRIP products were subjected to genomic DNA dot blot hybridization analysis with a probe containing the G-rich-telomere canonical repeat (TTAGGG), or a probe for α-satellite repeat, Alu, or LINE1 consensus sequence (Supplementary Data 1). ADAR1 depletion resulted in increased the formation of RNA:DNA hybrids specifically at telomeric repeats, which was abolished by E. coli-RNase H treatment prior to DRIP. c Significance of the increased R-loop formation at telomeric repeats was confirmed by conducting three independent dot blot hybridization analyses of DRIP products. Data are mean ± SD (n = 3, biological replicates); significant differences were identified by two-tailed Student’s t tests: **P < 0.01, n.s., not significant. a, c All individual experimental data values and exact P values are presented in Source Data file.
Fig. 4
Fig. 4. ADAR1p110 cannot edit completely matched RNA:DNA hybrids carrying telomeric repeat sequences.
a Canonical telomeric repeat sequences of G-strand RNA (red) and C-strand DNA (blue) are shown. Six adenosines of the G-strand RNA and twelve adenosines of the C-strand DNA are indicated by numbers 1–6 and 1–12, respectively. b In vitro editing assay for completely matched telomeric repeat dsRNA was conducted using ADAR1p110-WT recombinant protein. c In vitro editing assay for completely matched telomeric repeat RNA:DNA hybrids using ADAR1p110-WT recombinant protein. No significant levels of editing for matched RNA:DNA hybrids were detected. b, c PCR products (RT-PCR-amplified RNA strands and PCR-amplified DNA strands) were subjected to Sanger sequencing. The editing frequency was estimated as the % ratio of the guanosine (black) peak over the sum of guanosine and adenosine (green) peaks of the sequencing chromatograms. Editing frequency estimated for three independent experiments (n = 3, technical replicates) is presented in Supplemental information (Supplementary Data 2 and Source Data file).
Fig. 5
Fig. 5. Detection of telomeric variant repeats in ALT-positive and non-ALT cancer cell lines.
a Dot blot hybridization analysis for genomic DNA samples was conducted using three separate telomeric repeat probes capable of distinguishing a single-nucleotide mismatch (Supplementary Fig. 4a, b). In addition to canonical TTAGGG signals, varying amounts of TCAGGG and TTGGGG variant repeat signals were detected in both ALT and non-ALT cancer cell lines, but not in primary human fibroblast cells. b Quantitation of canonical and variant telomeric repeats was done by comparing dot blot signals of genomic DNA and canonical and variant repeat-specific control oligos. Three independent dot blot hybridization analyses were performed. Data are mean ± SD (n = 3, biological replicates). All individual experimental data values are presented in Source Data file.
Fig. 6
Fig. 6. Increased telomeric RNA:DNA hybrids containing variant repeats in ADAR1-depleted cells.
Formation of telomeric repeat RNA:DNA hybrids containing A–C mismatches by in cis slipped hybridization (a, b). a TERRA RNAs transcribed from the region containing four TCAGGG (green) variant repeats surrounded by TTAGGG (gray) canonical repeats form an RNA:DNA hybrid containing four C–A mismatches by in cis slipped hybridization to the C-strand DNA containing canonical TTAGGG (CCCTAA) repeats. b TERRA RNAs transcribed from the region containing four TTGGGG (orange) variant repeats surrounded by TTAGGG (gray) canonical repeats form an RNA:DNA hybrid containing four A–C mismatches by in cis slipped hybridization to the C-strand DNA containing TTGGGG (CCCCAA) variant repeats. c, d Detection of increased RNA:DNA hybrids containing TCAGGG and TTGGGG variant repeats in ADAR1-depleted HeLa cells. c DRIP products were examined for G-strand RNAs of UCAGGG variant and UUAGGG canonical repeats by dot blot analysis using high-affinity LNA-oligonucleotide probes capable of distinguishing a single-nucleotide mismatch (Supplementary Fig. 4c). d Similarly, DRIP products were examined for C-strand DNAs of TTAGGG (CCCTAA) canonical and TTGGGG (CCCCAA) variant repeats using LNA-oligonucleotide probes capable of distinguishing a single-nucleotide mismatch (Supplementary Fig. 4d). c, d Dot blot signals were abolished by E. coli-RNase H treatment prior to DRIP. The significance of the increase in RNA:DNA hybrids containing telomeric canonical and variant repeats (RNA and DNA strands) was confirmed by conducting three independent dot blot hybridization analysis of DRIP products. Data are mean ± SD (n = 3, biological replicates); significant differences were identified by two-tailed Student’s t tests: *P < 0.05, **P < 0.01, ***P < 0.001. All individual experimental data values and exact P values are presented in Source Data file.
Fig. 7
Fig. 7. ADAR1p110 edits both RNA and DNA strands of telomeric repeat RNA:DNA hybrids containing A–C mismatches.
ac In vitro editing assay for telomeric repeat dsRNA (a) and RNA:DNA hybrids (b, c) containing A–C or C–A mismatches was conducted using ADAR1p110-WT recombinant protein. PCR products (RT-PCR-amplified RNA strands and PCR-amplified DNA strands) were subjected to Sanger sequencing. Editing frequency estimated for three independent experiments (n = 3, technical replicates) is presented in Supplemental information (Supplementary Data 2 and Source Data file).
Fig. 8
Fig. 8. Editing of A–C mismatches in telomeric repeat RNA:DNA hybrids facilitates RNase H2 cleavage of RNA strands.
a F-ADAR1p110-WT recombinant protein was copurified with endogenous RNase H2 subunits H2A and H2C, but not with RNase H1. No RNase H2 association detected with a dsRNA-binding defective mutant F-ADAR1p110-EAA (upper panels). Similarly, FLAG-RNase H2A pulled down endogenous ADAR1p110 (lower panels). Note that both FLAG-AFAR1p110 and FLAG-RNase H2A pulled down endogenous TRF2, a telomere-binding protein and a member of the Shelterin complex, supporting our hypothesis that ADAR1 and RNase H2 collaborate together to resolve telomeric R-loops. Protein molecular weight markers are presented in Source Data file. b In vitro assay for digestion of 5′-32P-labeled RNA strands of telomeric repeat RNA:DNA hybrids by RNase H1 or RNase H2A/2B/2C complexes. RNase H2 could not degrade the RNA strands of telomeric repeat RNA:DNA hybrids containing six A–C mismatches, but began digesting RNA strands of RNA:DNA hybrids containing four A–C mismatches. Replacement of all A–C mismatches with I:C-matched base pairs resulted in efficient digestion of RNA strands by RNase H2. RNase H1 degraded RNA strands regardless of the number of A–C mismatches. c Time course of digestion of RNA strands of telomeric repeat RNA:DNA hybrids with varying numbers of A–C mismatches by RNase H1 or RNase H2. Data are mean ± SD (n = 4, technical replicates); significant differences were identified by two-tailed Student’s t tests: *P < 0.05, ***P < 0.001, n.s., not significant. All individual experimental data values and exact P values are presented in Supplementary Data 3. d A-to-I editing of A–C mismatches to I:C base pairs in RNA:DNA hybrids facilitates digestion of RNA strands by RNase H2.
Fig. 9
Fig. 9. ADAR1 regulates accumulation of telomeric R-loops only in non-ALT cells.
a Detection of increased RNA:DNA hybrids only in non-ALT cells. Genomic DNA samples (0.25 µg) collected from various cells treated with siControl or siADAR1-1 RNAs for 72 h were examined by dot blot assay using the S9.6 antibody. Data are mean ± SD (n = 3, biological replicates); significant differences were identified by two-tailed Student’s t tests: *P < 0.05, **P < 0.01, ***P < 0.001, n.s., not significant. b DRIP products from select cell lines were further subjected to dot blot analysis for the C-strand telomeric repeat DNA using the canonical telomeric repeat (TTAGGG) specific probe (Supplementary Fig. 4a). Telomeric repeat RNA:DNA hybrids were detected only in HEK293T and HCT116 non-ALT cancer cell lines. Data are mean ± SD (n = 3, biological replicates); significant differences were identified by two-tailed Student’s t tests: *P < 0.05, **P < 0.01, n.s., not significant. a, b All individual experimental data values and exact P values are presented in Source Data file.
Fig. 10
Fig. 10. M-phase-specific interaction of ADAR1p110 and RNase H2 in non-ALT cancer cells.
a Elevated ADAR1 and RNase H2A expression levels detected in non-ALT cells. Western blotting analysis was performed using total cell extract proteins and specific antibodies (Supplementary Data 4). b Interaction between ADAR1p110 and RNase H2 detected only in non-ALT cancer cells. FLAG-ADAR1p110-WT recombinant protein was copurified with endogenous RNase H2 subunit H2A only from non-ALT cell lines. c Elevated RNase H2A expression levels and also increased interaction of ADAR1p110 with RNase H2A detected specifically at M phase. FLAG-ADAR1p110-WT pull-down experiments were conducted using HEK293T cells synchronized at M phase using the thymidine-nocodazole double block system. ac Protein molecular weight markers are presented in Source Data file.

References

    1. Eisenberg E, Levanon EY. A-to-I RNA editing - immune protector and transcriptome diversifier. Nat. Rev. 2018;19:473–490. doi: 10.1038/s41576-018-0006-1. - DOI - PubMed
    1. Nishikura K. A-to-I editing of coding and non-coding RNAs by ADARs. Nat. Rev. Mol. Cell Biol. 2016;17:83–96. doi: 10.1038/nrm.2015.4. - DOI - PMC - PubMed
    1. Walkley CR, Li JB. Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs. Genome Biol. 2017;18:205. doi: 10.1186/s13059-017-1347-3. - DOI - PMC - PubMed
    1. Mannion N, Arieti F, Gallo A, Keegan LP, O’Connell MA. New insights into the biological role of mammalian ADARs; the RNA editing proteins. Biomolecules. 2015;5:2338–2362. doi: 10.3390/biom5042338. - DOI - PMC - PubMed
    1. Samuel CE. Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses. J. Biol. Chem. 2019;294:1710–1720. doi: 10.1074/jbc.TM118.004166. - DOI - PMC - PubMed

Publication types